This article was reviewed by David S. Boyer, MD
Medical management of orbital inflammatory disease (OID) is based on the use of non-specific and specific immunomodulatory drugs. Patient care is optimized by determining underlying etiology for the inflammation, according to Louise A.
When a physician seeks to determine a diagnosis and subsequent course of action for a patient, the clinical value of every step in that process is first and foremost.
This article was reviewed by Irmgard Behlau, MD